|
Can-Fite BioPharma Ltd. (CANF) DCF Valuation
IL | Healthcare | Biotechnology | AMEX
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Can-Fite BioPharma Ltd. (CANF) Bundle
Discover the true potential of Can-Fite BioPharma Ltd. (CANF) with our advanced DCF Calculator! Adjust key assumptions, explore various scenarios, and evaluate how changes influence Can-Fite BioPharma Ltd. (CANF) valuation – all within a single Excel template.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.0 | .8 | .9 | .8 | .7 | .6 | .5 | .4 | .4 | .3 |
| Revenue Growth, % | 0 | -62.45 | 11.8 | -5.04 | -8.27 | -15.99 | -15.99 | -15.99 | -15.99 | -15.99 |
| EBITDA | -12.0 | -14.1 | -12.8 | -10.1 | -8.2 | -.6 | -.5 | -.4 | -.4 | -.3 |
| EBITDA, % | -590.21 | -1851.51 | -1503.87 | -1244.69 | -1100.94 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 0.68893 | 1.57 | 1.64 | 1.73 | 2.02 | 1.53 | 1.53 | 1.53 | 1.53 | 1.53 |
| EBIT | -12.0 | -14.1 | -12.8 | -10.1 | -8.2 | -.6 | -.5 | -.4 | -.4 | -.3 |
| EBIT, % | -590.9 | -1853.08 | -1505.51 | -1246.42 | -1102.96 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 2.8 | 8.3 | 19.1 | 8.0 | 8.9 | .6 | .5 | .4 | .4 | .3 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 0 | 2.36 | 5.63 | 5.8 | 0 | 2.76 | 2.76 | 2.76 | 2.76 | 2.76 |
| Inventories | .0 | 1.0 | .0 | .0 | .0 | .1 | .1 | .1 | .1 | .1 |
| Inventories, % | 0 | 126.34 | -5.63 | -4.81 | 0 | 17.91 | 17.91 | 17.91 | 17.91 | 17.91 |
| Accounts Payable | 2.2 | .6 | 1.0 | .9 | .4 | .5 | .5 | .4 | .3 | .3 |
| Accounts Payable, % | 106.1 | 73.53 | 111.84 | 110.62 | 57.47 | 86.2 | 86.2 | 86.2 | 86.2 | 86.2 |
| Capital Expenditure | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | -0.14764 | -3.41 | -1.29 | -1.11 | -0.26918 | -1.25 | -1.25 | -1.25 | -1.25 | -1.25 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -12.0 | -14.1 | -12.8 | -10.1 | -8.2 | -.6 | -.5 | -.4 | -.4 | -.3 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -9.8 | -16.7 | -11.5 | -10.2 | -8.6 | -.6 | -.6 | -.5 | -.4 | -.3 |
| WACC, % | 6.07 | 6.07 | 6.07 | 6.07 | 6.07 | 6.07 | 6.07 | 6.07 | 6.07 | 6.07 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -2.1 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | -9 | |||||||||
| Present Terminal Value | -7 | |||||||||
| Enterprise Value | -9 | |||||||||
| Net Debt | -4 | |||||||||
| Equity Value | -4 | |||||||||
| Diluted Shares Outstanding, MM | 4 | |||||||||
| Equity Value Per Share | -1.03 |
What You Will Get
- Real CANF Financials: Access to historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
- Scenario Analysis: Explore various scenarios to assess Can-Fite BioPharma's future performance.
- User-Friendly Design: Tailored for experts but easy to navigate for newcomers.
Key Features
- Customizable Clinical Parameters: Adjust essential inputs such as trial success rates, market penetration, and R&D costs.
- Instant DCF Valuation: Automatically computes intrinsic value, NPV, and related metrics in real-time.
- High Precision Results: Leverages Can-Fite's actual financial data for credible valuation insights.
- Effortless Scenario Testing: Evaluate various assumptions and analyze results with ease.
- Efficiency Booster: Streamline the valuation process without the hassle of complex model creation.
How It Works
- Download the Template: Gain immediate access to the Excel-based CANF DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other parameters.
- Instant Calculations: The model automatically recalculates Can-Fite BioPharma's intrinsic value.
- Test Scenarios: Experiment with different assumptions to assess potential valuation variations.
- Analyze and Decide: Utilize the results to inform your investment or financial analysis.
Why Choose Can-Fite BioPharma Ltd. (CANF)?
- Innovative Solutions: Focuses on developing advanced therapies for cancer and autoimmune diseases.
- Robust Pipeline: Features a diverse range of clinical-stage assets with promising results.
- Expert Team: Led by industry veterans with extensive experience in biotechnology and pharmaceuticals.
- Strong Partnerships: Collaborates with leading institutions and organizations to enhance research and development.
- Market Potential: Positioned in high-demand therapeutic areas with significant growth opportunities.
Who Should Use This Product?
- Individual Investors: Make informed decisions about buying or selling Can-Fite BioPharma Ltd. (CANF) stock.
- Financial Analysts: Streamline valuation processes with ready-to-use financial models for Can-Fite BioPharma Ltd. (CANF).
- Consultants: Deliver professional valuation insights on Can-Fite BioPharma Ltd. (CANF) to clients quickly and accurately.
- Business Owners: Understand how biotech companies like Can-Fite BioPharma Ltd. (CANF) are valued to guide your own strategy.
- Finance Students: Learn valuation techniques using real-world data and scenarios focused on Can-Fite BioPharma Ltd. (CANF).
What the Template Contains
- Historical Data: Includes Can-Fite BioPharma Ltd.’s (CANF) past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Can-Fite BioPharma Ltd.’s (CANF) intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of Can-Fite BioPharma Ltd.’s (CANF) financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.